1. OC-0373: SBRT versus TAE/TACE in Hepatocellular Carcinoma: results from a Phase III trial (NCT02323360). (November 2020) Authors: Comito, T.; Loi, M.; Franzese, C.; Clerici, E.; Pedicini, V.; Poretti, D.; Solbiati, L.; Rimassa, L.; Scorsetti, M. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications. (February 2020) Authors: Masetti, C.; Pugliese, N.; Messana, G.; Ceriani, R.; Poretti, D.; LLeo, A.; Lanza, E.; Colombo, M.; Personeni, N.; Pedicini, V.; Torzilli, G.; Aghemo, A. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗